Answers are grounded in this paper and cite their sources.
This study compared the efficacy of flomoxef with other β-lactam antibiotics against extended-spectrum β-lactamases (ESBL)-producing bacteria of clinical relevance. First, the prevalence and β-lactamase genotypes of ESBL-producing strains among Escherichia coli and Klebsiella pneumoniae isolates collected in Japan from 2004 to 2018 were investigated. High MIC₉₀ values (>64 µg/mL) of ceftriaxone, cefepime, and ceftazidime and low MIC₉₀ values (≤0.06-2 µg/mL) of flomoxef, cefmetazole, and meropenem against both species were observed. Second, a chemostat model was used to analyze the efficacy of humanized regimens of three oxacephem/cephamycin antibiotics (flomoxef, cefmetazole, cefoxitin) and two other antibiotics (meropenem and piperacillin/tazobactam) in suppressing the growth of five ESBL-producing E. coli and two K. pneumoniae strains. Flomoxef, piperacillin/tazobactam, and meropenem showed good bactericidal effects with >4 log₁₀ CFU/mL reduction without bacterial regrowth at 24 h even when the MIC of test isolates was >MIC₉₀. Cefmetazole and cefoxitin resulted in regrowth of test isolates with MIC ≥MIC₉₀ at 24 h. Cefmetazole, cefoxitin, flomoxef, and meropenem showed increased MICs for regrown samples. A clear relationship between the proportion of time that the free drug concentration exceeded the MIC (%fT>MIC) and antibiotic efficacy was found for flomoxef, cefoxitin, and cefmetazole, and flomoxef had the highest %fT>MIC, whereas discrepancies between Clinical and Laboratory Standards Institute breakpoint and bactericidal activity were observed for cefmetazole. Flomoxef was effective in preventing the growth of all ESBL-producing strains, even those with an MIC eight times the MIC₉₀. Thus, flomoxef may be a good alternative to meropenem in context of carbapenems sparing stewardship.
No takes yet. Share an insight, caveat, or question.
Yamashiro et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: